Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe label for the 'Find contact information' link was standardized in the UI (capitalization change). The record history section now shows Revision: v3.7.0 instead of v3.6.6, reflecting a site update.SummaryDifference0.2%

- Check36 days agoChange DetectedA new revision v3.6.6 has been added to the study record history, replacing the previous v3.6.5. This reflects an update to the record metadata rather than substantive content changes.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry Revision: v3.6.5 appears in the history. This replaces the previous Revision: v3.6.4 and signals a page version update.SummaryDifference0.1%

- Check72 days agoChange DetectedThe study record history now shows the latest revision as v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page's revision metadata in the history view.SummaryDifference0.1%

- Check93 days agoChange DetectedThe record history now includes a new revision labeled v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check101 days agoChange DetectedA new revision entry (v3.6.2) was added to the study's record history and the older revision (v3.6.0) was removed from the list. This reflects an update to the page's version history rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.